Zobrazeno 1 - 10
of 651
pro vyhledávání: '"P, Litwak"'
Autor:
León Litwak
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 57, Iss 3Sup (2023)
Durante mucho tiempo se asoció fenotípicamente la diabetes mellitus tipo 1 (DM1) con pacientes de aspecto delgado y, en algunos casos, subnutridos. Sin embargo, este fenotipo fue cambiando dado que, en las últimas décadas, el sobrepeso y la obesi
Externí odkaz:
https://doaj.org/article/db311b3a202f4437bd3a5bec404d24ab
Autor:
León Litwak
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 55, Iss 3Sup, Pp 41-59 (2021)
The tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. It can be modifi
Externí odkaz:
https://doaj.org/article/61e7075a7a5546eaa424f2f16db704ea
Autor:
José Álvarez, Florencia Aranguren, Fernando Belcastro, Fernando Brites, Carlos Buso, Marta Calvagno, Christian Caroli, Leonardo Celano, Hernán Cohen Arazi, Daniel Comtesse, Pablo Corral, Juan Pablo Costabel, Alicia Elbert, Cristina Faingold, Graciela Fuente, Pablo García Merletti, Mariano Aníbal Giorgi, Gustavo Giunta, Héctor Gómez Santamaría, Enrique González Naya, Claudio Hadid, Ariel Kraselnik, Augusto Lavalle Cobo, León Litwak, Martín Lobo, Alfredo Lozada, Claudio Majul, Walter Masson, Carla Musso, Juan Nogueira, Gabriel Persi, Martín Rodríguez, Emiliano Salmeri, Hugo Sanabria, Silvio Schraier, Isaac Sinay, Daniel Siniawski, Jorge Thierer, Susana Salzberg, Cristian Suárez Cordo, Jorge Lerman, Álvaro Sosa Liprandi
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 55, Iss 1Sup, Pp 03-70 (2021)
This Consensus comes to light in the midst of one of the worst global health crises in the last 100 years. SARS-CoV-2 and its clinical manifestation, COVID-19, have caused a disruption in how doctors and patients interact. Although it is an infectiou
Externí odkaz:
https://doaj.org/article/b046cc52ada24d0084c34e8ffe8a63b6
Autor:
León Litwak, Nancy Carreño, Rodrigo Carnero, Alejandro Dain, Luis Grosembacher, Carla Musso, Adrián Proietti, Lucas Rista, Gabriela Rovira, Graciela Rubin, María Ruiz, Antonio Saleme, Liliana Trifone, José Costa Gil
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3, Pp 140-154 (2020)
The tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Self-blood gluco
Externí odkaz:
https://doaj.org/article/e74df672411742c48b6635738453d5c5
Autor:
Paola Polo, María Graciela Álvarez, Eduardo Babor, Maia Herrero, Sandra González, María Yuma, Isaac Sinay, León Litwak, Susana Gutt, Susana Fuentes, Carla Musso, Marianela Aguirre Ackermann
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 53, Iss 3Sup, Pp 139-142 (2020)
Introduction: obesity is a serious growing medical problem in type 1 diabetes mellitus (DM1). Insulin replacement is the only available therapy for these patients with DM1 and the main problems associated with it are hypoglycemia and weight gain. Bar
Externí odkaz:
https://doaj.org/article/929d932a221e42ccb1383b1729449e2d
Autor:
Tingting Ge, Amber‐Lee Phung, Gaurang Jhala, Prerak Trivedi, Nicola Principe, David J De George, Evan G Pappas, Sara Litwak, Laura Sanz‐Villanueva, Tara Catterall, Stacey Fynch, Louis Boon, Thomas W Kay, Jonathan Chee, Balasubramanian Krishnamurthy, Helen E Thomas
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 11, Pp n/a-n/a (2022)
Abstract Objectives Immune checkpoint inhibitors have achieved clinical success in cancer treatment, but this treatment causes immune‐related adverse events, including type 1 diabetes (T1D). Our aim was to test whether a JAK1/JAK2 inhibitor, effect
Externí odkaz:
https://doaj.org/article/2f238a260da54aefb12d7ef799742c6b
Autor:
Michele Quan, MD, MPH, Nam Cho, PharmD, Thomas Bushell, PharmD, Joseph Mak, DO, Nolan Nguyen, Jane Litwak, PharmD, Nicholas Rockwood, PhD, MAS, MA, H. Bryant Nguyen, MD, MS
Publikováno v:
Critical Care Explorations, Vol 4, Iss 1, p e0623 (2022)
IMPORTANCE:. Angiotensin II (ATII) was approved for septic or other distributive shock due to its property of increasing blood pressure within 3 hours. Limited data exist regarding its effectiveness when used in real-world clinical practice. OBJECTIV
Externí odkaz:
https://doaj.org/article/cc4f83ed6b344f8baba613fa681d4fd0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
León Litwak
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 56, Iss 3Sup, Pp 4-4 (2022)
An adequate glycemic control prevents and/or delays the development and/or progression of chronic complications in patients with Diabetes Mellitus (DM). To achieve this control, it is necessary to adjust insulin doses, in type 1 or insulinized type 2
Externí odkaz:
https://doaj.org/article/56297baf31984e009a56547a95b5d30c
Autor:
León Litwak
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 56, Iss 3Sup, Pp 109-109 (2022)
An adequate glycemic control prevents and/or delays the development and/or progression of chronic complications in patients with Diabetes Mellitus (DM). In order to adjust insulin doses, in type 1 or insulinized type 2 DM patients, with multiple insu
Externí odkaz:
https://doaj.org/article/c6619b094eb94a5381512a4915d161ee